Infusion of a stable prostacyclin analogue, iloprost, to patients with peripheral vascular disease: lack of antiplatelet effect but risk of thromboembolism
- 1 January 1991
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 90 (1) , 41-46
- https://doi.org/10.1016/0002-9343(91)90504-q
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliteransThe Lancet, 1990
- Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarctionJournal of the American College of Cardiology, 1989
- Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.BMJ, 1989
- Iloprost, ein stabiles Prostacyclinderivat, bei arterieller Verschlußkrankheit im Stadium IV: Eine placebo-kontrollierte MultizenterstudieDeutsche Medizinische Wochenschrift (1946), 1989
- Platelet actions of stable carbocyclic analogues of prostacyclin.Circulation, 1985
- ALTERED PLATELET FUNCTION IN PATIENTS ON CONTINUOUS INFUSIONS OF EPOPROSTENOLThe Lancet, 1984
- Early and late administration of a PGI2-analogue, ZK 36 374 (iloprost): effects on myocardial preservation, collateral blood flow and infarct sizeCardiovascular Research, 1984
- Inhibition of platelet aggregation and antagonism of vasopressin-induced ECG changes in primates by a carboprostacyclin analogue, ZK 36374Thrombosis Research, 1984
- Prevention of occlusive coronary artery thrombosis by prostacyclin infusion in the dog.Circulation, 1981
- Intermittent claudication and rest pain: Physiologic concepts and therapeutic approachesProgress in Cardiovascular Diseases, 1979